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OBJECTIVES The goal of this study was to investigate the genotype-to-phenotype relationship between
SCN5A gene mutation and progressive cardiac conduction defect in order to gain insights into
the pathophysiologic mechanisms of the disease.
BACKGROUND Progressive cardiac conduction defect is a frequent disease commonly attributed to degener-
ation and fibrosis of the His bundle and its branches. In a French family, we have identified
a splicing mutation in the SCN5A gene leading to hereditary progressive cardiac conduction
defect.
METHODS We have extended the size of the pedigree and phenotyped and genotyped all family
members, and also investigated in vitro the functional consequences of the mutation.
RESULTS Among 65 potentially affected members, 25 individuals were carriers of the IVS.222 T3C
SCN5A mutation. In relation to aging, gene carriers exhibit various types of conduction
defects. P-wave, PR, and QRS duration increased progressively with age in gene carriers and
in noncarriers. Whatever the age, conduction parameters were longer in gene carriers. The
widening in the QRS complex with aging was more pronounced in gene carriers older than
40 years. Functional studies show that the IVS.222 T3C SCN5A mutation lead to exon
22 skipping and to a complete loss of function of the affected allele, but to a normal trafficking
of the mutated gene product.
CONCLUSIONS Our findings demonstrate that hereditary Lene`gre disease is caused by a haploinsufficiency
mechanism, which in combination with aging leads to progressive alteration in conduction
velocity. (J Am Coll Cardiol 2003;41:643–52) © 2003 by the American College of
Cardiology Foundation
Progressive cardiac conduction defect is characterized by an
age-related alteration in the conduction of the cardiac
impulse through the His-Purkinje system. Progressive car-
diac conduction defect, also called Lene`gre or Lev’s disease,
is a frequent affection that remains a major cause of
pacemaker implantation (1). It is commonly thought that
the disease issues from a slow process developing over
decades, affecting the His bundle and its branches (2).
Lene`gre and Lev hypothesized that it was a primary
degenerative disease or an exaggerated aging process of
unknown origin with sclerosis selectively affecting the con-
ducting tissue (2,3). As early as the 1970s, familial investi-
gation of patients with chronic bifascicular block (4) or
complete atrioventricular (AV) block (5) suggested that
genetic factors could be involved in the pathophysiology of
the disease. Hereditary cases of bundle branch block have
often been reported (6–10). In 1995, a first locus was
mapped to 19q13.2-13.3 (11). More recently, we reported a
large French family in which a cardiac conduction defect
was transmitted as an autosomal dominant trait and was
caused by a splicing mutation (IVS.222 T3C) in the
SCN5A gene coding for the cardiac-specific sodium channel
(12). SCN5A is the first identified gene responsible for
hereditary Lene`gre disease.
We have now extended the size of the pedigree and
genotyped and phenotyped all family members. In addition,
we have investigated in vitro the functional consequences of
the mutation with the objective to gain better insight into
the pathophysiology of the disease. Our findings demon-
strate that mutation in the SCN5A gene induces a progres-
sive alteration in the conduction of the cardiac impulse in
the atria as well as the ventricle. The cardiac conduction
defect already present in infancy worsened progressively
with age, leading to the typical aspect of the idiopathic
progressive conduction block as originally described by
Lene`gre and by Lev. We also show that hereditary Lene`gre
disease is caused by a haploinsufficiency mechanism, which
in combination with aging leads to progressive alteration of
the conduction velocity.
METHODS
Clinical investigation. The study was conducted accord-
ing to the French guidelines for genetic research and was
approved by the ethical committee of Nantes University
Hospital. Informed written consent was obtained for each
family member who agreed to participate in the study. In
this family, members of generation I were 10 brothers and
sisters of Patient I-11 (Fig. 1). Overall, we identified a large
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family of more than 200 members. Sixty-five potentially
affected members who agreed to participate in the study
were selected. All 65 members were genotyped by direct
sequencing of exon 22 (ABI 377 automated sequencer).
Subjects were considered as gene carriers if they were
carrying the IVS.222 T3C splicing mutation in the
SCN5A gene. Clinical investigation included a review of
medical history, a physical examination, and a 12-lead
electrocardiogram (ECG). Heart rate, PR interval, QRS,
QT, QTc duration, and P and QRS axis were measured
automatically at rest (Mac Vu Marquette Inc., Milwaukee,
Wisconsin). QRS axis was classified as normal when its
value was between 30° and 90°. Out of this range it was
classified as abnormal. Conduction defects were defined
using the conventional classification (13,14). Parietal block
was defined as a QRS wider than 115 ms without morphol-
ogy of left bundle branch block (LBBB) or right bundle
branch block (RBBB). PR duration shorter than 210 ms was
considered normal. A limitation of standard ECG remains
the assessment of the P-wave and QRS duration. To
increase the accuracy of these measurements, we performed
signal-averaging electrocardiogram for P and QRS com-
plexes using commercially available software (Mac Vu Mar-
quette Inc., Milwaukee, Wisconsin). Measures were per-
formed using 40 to 250 Hz filters.
Exon trapping experiments. A 6 Kb SCN5A genomic
fragment containing exon 21 to exon 23 was polymerase
chain reaction (PCR) amplified (Expand 20 Kb PCR
System; Roche Molecular Diagnostic) using deoxyribonu-
cleic acid from a gene carrier as template. Primers were
designed to flank exon 21 and 23 and to introduce a Not I
restriction site (Int-20-F: ATAAGAATGCGGCCGCT-
TCATGTCCACCTGTCT; Int-23-R: ATAAGAAT-
GCGGCCGCATTGGGAGGAAGGAAGTC). Poly-
merase chain reaction products were Not I digested and
subcloned into a pSPL3 exon-trapping vector (Exon Trap-
ping System; Life Technologies). Direct sequencing of
recombinant clones was used to identify wild-type (WT)
and mutant genomic fragments. Mutated and WT pSPL3-
exon 21-23 plasmids were transfected into COS-7 cells,
using polyethylenimine (PEI 22kDa). Forty-eight hours
post-transfection, cells were harvested and total ribonucleic
acid was extracted. Total ribonucleic acid was retro-
transcribed with SA2 primer according to manufacturer
specifications and PCR amplified using exonic primers
(Ex-21-F: GGCTCGACTTCCTCATCGTA; Ex-23-R:
CTGGCTCTTGTTGTTCACGA). Amplification prod-
ucts were run on a 1.7% TBE agarose gel and formally
characterized by direct sequencing.
Functional studies. Our method to record inward currents
in COS-7 SCN5A-transfected cells has previously appeared
(15). Briefly, using PEI 22kDa, COS-7 cells were trans-
fected with either WT SCN5A plasmid or a mutated
plasmid lacking exon 22 (exon 22-SCN5A). Twenty-four
hours post-transfection, currents were recorded at room
temperature using the whole-cell configuration of the
patch-clamp technique. Current measurements were nor-
malized using cell capacitance. The pipette medium con-
tained (mmol/l): NaCl 10, CsCl 64.5, aspartic acid 70.5,
HEPES 5, and pH 7.2 with CsOH; the extracellular
medium used to record Na currents contained (mmol/l):
NaCl 145, CsCl 4, CaCl2 1, MgCl2 1, HEPES 5, glucose
5, and pH 7.4 with NaOH.
For imaging, cells transfected with GFP-tagged channel
plasmids (either WT or exon 22 deleted) were fixed for 15
min with 4% (v/v) paraformaldehyde in phosphate-buffered
saline (in mmol/l: Na2HPO4 9.1, NaH2PO4 1.7, NaCl 150,
pH adjusted to 7.4 with NaOH). Cells were rinsed twice
and the coverslips were mounted in Mowiol. The cells were
observed with an epifluorescence microscope using interfer-
ence blue (fluorescein isothiocyanate) filter and an oil-
immersion 100 lens. They were also imaged with a
scanning laser confocal microscope using 488 nm illumina-
tion and an oil-immersion 100 lens.
Statistical methods. Clinical data are expressed as mean
value  SD. The duration of PR, QRS, and P-wave were
compared with Student t test. A p value of 0.05 was
considered to be significant. Simple and piecewise linear
regression analyses were performed for the effect of aging on
conduction parameters (16). Model thresholds were tested
by the mean of F ratio test. Patch-clamp data are expressed
as mean  SEM. Statistical significance of the observed
effects was assessed by means of the t test or two-way
analysis of variance when needed.
RESULTS
Clinical phenotype. Within the 65 living members in-
cluded in the study, 25 were carrying the splice mutation
whereas 40 were noncarriers (Fig. 1). Eight patients had
complete RBBB associated with (Patients: III-29, IV-1,
IV-16, IV-18) or without (Patients: III-27, III-31, III-32,
IV-19) a left posterior hemibloc (LPHB). One had incom-
plete RBBB (Patient III-20). Two had complete LBBB
(II-20, III-28). One had an isolated left anterior hemibloc
(LAHB) (Patient III-23). One patient had isolated LPHB
(II-2). Eight patients had parietal blocks in the absence
(Patients: III-1, III-2, III-7, III-25, IV-20) or presence
(Patients: II-3, II-15, II-19) of a left-axis deviation. Ten




LAHB  left anterior hemiblock
LBBB  left bundle branch block
LPHB  left posterior hemiblock
PCR  polymerase chain reaction
RBBB  right bundle branch block
WT  wild-type
644 Probst et al. JACC Vol. 41, No. 4, 2003
SCN5A-Linked Hereditary Lene`gre Disease February 19, 2003:643–52
II-20, III-2, III-23, III-25, III-27, III-28, III-29, III-32).
Four patients (an 11-year-old boy [Patient IV-2] and three
women of 36 [Patient III-6], 47 [Patient III-8], and 50
years [Patient III-24]) had an ECG within the normal
limits. Examples of abnormal ECG patterns are shown in
Figure 2. No member of this family showed ST-segment
elevation in the right precordial leads.
Among the affected patients, seven had symptoms in
relation with their conduction defect. Syncope occurring at
rest was the most common symptom, leading to pacemaker
implantation in six patients (Patients: II-3, II-15, II-19,
II-20, III-25, III-31). In Patient III-25, for example, an
electrophysiologic test was conducted because of syncope
and parietal block (QRS: 164 ms). The HV interval was
55 ms at baseline and increased to 120 ms after ajmalin
injection (1 mg/kg as an intravenous bolus). In this patient,
ajmalin produced no ST-segment elevation in the right
precordial leads. When she was admitted for pacemaker
implantation, she had a cardiac arrest attributable to com-
plete AV block, necessitating cardiopulmonary resuscita-
tion. All patients equipped with a pacemaker remained free
of symptoms.
Mean age of affected and unaffected family members was
48  20 years and 40  18 years, respectively (nonsignifi-
cant, NS). On average, their systolic blood pressure was
121 14 mm Hg for the affected and 125 12 mm Hg for
the unaffected (NS), whereas the diastolic pressure was 77
9 mm Hg and 73  9 mm Hg, respectively (NS). An
echocardiography was performed in every family member
older than 40 years. No structural anomalies were evi-
denced. The ECG parameters of family members are shown
in Figure 3. On average, the heart rate was slower among
gene carriers (68  10 beats/min) in comparison with
noncarriers (75 11 beats/min; p 0.03). The PR interval
was longer in affected members than in the unaffected
subjects (206 33 ms vs. 149 22 ms, p 0.00001). QRS
duration was longer in the affected group than in the
unaffected group (130  28 ms vs. 95  13 ms, p 
0.00001). The QTc duration was similar in both groups
(423  29 ms vs. 415  19 ms). The duration of the
averaged and filtered P-wave was longer in the affected than
in the unaffected group (143  13 ms vs. 119  13 ms; p 
0.0001). Finally, the averaged and filtered QRS duration
was also longer in affected family members (140 20 ms vs.
116  10 ms, p  0.0001). In the gene-carrier population,
there were no differences in the conduction parameters that
could be related to gender. Conduction parameters were
also compared between noncarriers and an age- and gender-
matched population of control patients (n  122). No
significant differences were found, thus suggesting that
noncarriers did not carry a latent conduction defect.
Progressive development of the conduction defect. A
major feature of the phenotype was the progressive devel-
opment of cardiac conduction defect in relation to age. Two
sets of data showed progressive alteration in the conduction.
Figure 1. Pedigree of the four-generation family with progressive cardiac
conduction defect. Filled symbols  patients carrying the mutation or
obligate carriers; open symbols  noncarriers. PM  patients with a
pacemaker.
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In five patients, serial ECGs were obtained over an 11- to
16-year period before the present study (Table 1). In five
patients, the QRS duration consistently increased with
aging. In four patients, the PR duration behaved similarly.
A typical example of the evolution of ECG patterns is
shown in Figure 4.
The age of the patients who participated to the study
ranged from 15 to 81 years. We plotted conduction param-
eters in relation to age (Fig. 5). Whatever the age, averaged
and filtered P-wave, PR, and QRS duration were longer in
affected patients than in unaffected. There was a shift in the
regression line for P-wave and PR duration toward higher
values in affected patients, whereas the slopes, expressed in
ms per year, were comparable in the two groups. The
increase in averaged and filtered P-wave and PR duration
were 0.37 ms/year versus 0.47 ms/year and 0.88 ms/year
versus 0.60 ms/year for unaffected and affected members,
respectively. In contrast, the QRS duration evolved differ-
ently in relation to age between the two groups. In general,
there was a more pronounced QRS lengthening with age in
affected than in unaffected patients. In addition, an age-
dependent variability in the QRS duration was evidenced in
Figure 2. Examples of electrocardiogram patterns in affected members. Patient II-19 was a 70-year-old woman with parietal block and left-axis deviation
(heart rate [HR]: 64 beats/min, P: 144 ms, PR: 215 ms, QRS: 160 ms). A pacemaker was implanted because of several episodes of syncope. Patient III-2
was a 49-year-old man with a parietal block and undetermined axis (HR: 54 beats/min, P: 150 ms, PR: 244 ms, QRS 128 ms). Patient III-31 was a
48-year-old woman with right bundle branch block (HR: 64 beats/min, P: 153 ms, PR: 205 ms, QRS: 172 ms). Sudden widening of QRS complexes and
occurrence of 2-1 atrioventricular block during exercise led to pacemaker implantation. Patient II-20 was a 78-year-old woman with left bundle branch block
(HR: 59 beats/min, P: 157 ms, PR: 248 ms, QRS: 196 ms). A pacemaker was implanted after two episodes of syncope.
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the affected group. The variance was significantly different
before and after the age of 40 (ratio variance test; p  0.001),
indicating a threshold effect of age. Therefore, a piecewise
linear regression was conducted in the affected group. This
variability was not found in the unaffected group, demonstrat-
ing a differential evolution of the QRS duration over aging.
When the subgroup of patients younger than 40 years was
considered (7 affected and 19 nonaffected), conduction param-
eters were also prolonged in the affected group (P-wave
duration 132 12 ms vs. 115 10 ms, p 0.002; PR 179
11 ms vs. 140  20 ms, p  0.00001; and QRS duration 116
 8 ms vs. 92 14 ms, p 0.0001). These data demonstrate
that a conduction anomaly was already present early in life in
the absence of specific conduction defects, which were never
observed before 40 years.
Functional consequences of the IVS.222 T3C splice
mutation. Given that SCN5A expression is cardiac specific
(17) and no cardiac tissue was available from affected
individuals, the abnormal transcripts resulting from the 2
donor splice mutation were characterized in vitro. Muta-
tions in a consensus splice site should result in abnormal
splicing. The abnormal transcript is predicted to an in-
frame skipping of exon 22 and an impaired gene product
missing the voltage-sensitive DIIIS4 segment. To further
support this assumption, we conducted exon-trapping ex-
periments of the mutated gene. As illustrated in Figure 6,
transcripts obtained with the mutated construct showed
exon 22-deletion, as demonstrated by direct sequencing.
Wild-type and exon 22-deleted SCN5A cardiac sodium
channels were then expressed in COS-7 cells. Illustrative
current traces are shown in Figure 7. In cells transfected
with the WT SCN5A plasmid, the peak inward current
density was 59.3  10.5 pA/pF (test potential at 20
mV; n  8). The Na channel beta-1 subunit has been
shown to increase SCN5A expression in Xenopus oocytes
(18). In COS-7 cells expressing WT SCN5A plus beta-1
subunit, an increase in peak-current density was also ob-
served (112.9  24.2 pA/pF; n  12). In contrast, in 10
experimental cells transfected with the exon 22-SCN5A
mutant alone and in nine additional cells co-transfected
with exon 22-SCN5A plus beta-1 subunit, no transient
inward current was recorded in response to depolarization.
In order to investigate the consequences of mutation on
protein maturation, we expressed WT and exon22-
SCN5A-GFP fusion proteins in mammalian cells. Figure 7,
E, shows pictures of representative transfected cells ob-
served with either conventional epifluorescence or laser
confocal microscopy. These data suggest that the mutated
exon22 SCN5A protein was correctly processed to the cell
membrane.
Figure 3. Averaged electrocardiogram parameters in noncarriers (white bars) and in gene carriers (black bars). *Statistical significance. HR  heart
rate.
Table 1. Serial Electrocardiogram Parameters in Five Affected Family Members
Patient # Year PR (ms) QRS (ms) Year PR (ms) QRS (ms)
III-28 1987 240 160 1998 253 180
III-29 1982 220 130 1998 230 180
III-31 1982 200 130 2000 205 172
II-15 1986 200 150 1998 208 160
II-3 1985 200 160 1998 230 170
Mean 212 146 225 172.4
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DISCUSSION
The present study shows that the pathophysiology of the
hereditary Lene`gre disease related to SCN5A combines
haploinsufficiency of the cardiac Na channel gene and an
additional mechanism of unknown nature altering cardiac
conduction in relation to aging. The present data also
suggest that this latter mechanism may be a physiologic
process, because progressive lengthening of conduction
times also occurs (although less markedly) in noncarriers
from the same pedigree. In idiopathic (acquired) Lene`gre
disease, chronic cardiac conduction defect progressively
develops over decades, leading to complete AV block. In the
pedigree reported here, the progressive development of the
Figure 4. Serial electrocardiograms performed in Patient III-31 showing progressive development of conduction defect. Electrocardiograms recorded in
1982, 1998, and 2000 show progressive increase in QRS duration (QRS: 130, 140, and 172 ms).
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conduction defects was comparable to that observed in
idiopathic Lene`gre disease. In addition, all types of intra-
ventricular conduction defects (such as LBBB, RBBB,
LAHB, and LPHB) were present in the family as in the
classical description of the idiopathic Lev-Lene`gre disease.
Several investigators (1,2) have dismissed the ischemic
hypothesis, and acquired Lene`gre disease is regarded as a
degenerative process in relation to age. On the basis of
histologic studies, Lene`gre and Lev hypothesized that
progressive AV block was caused by progressive fibrosis of
the His bundle and its branches (2,3). However, fibrosis of
the conduction network is also observed in the elderly in the
absence of conduction defect (19). Thus, we postulate that
hereditary Lene`gre disease results from a genetic defect of
the Na channel that exacerbates the natural age-related
progressive conduction slowing caused by fibrosis or an
alternative process.
In the present family, young affected patients had an
ECG within normal limits. Using selective criteria, that is,
the presence of specific conduction defects, complete pen-
etrance is late during aging. However, even in young
patients, P, PR, and QRS duration were longer compared
with the unaffected group. More accurate criteria for con-
duction parameters in relation to age are needed to identi-
fying affected patients in their younger age. A 50% reduc-
tion in the number of functional sodium channels should
result in a consistent reduction in the speed of propagation
of the cardiac impulse and hence in a prolongation of the
conduction parameters. Why was conduction so slightly
affected in young patients? There are several possibilities to
consider. It may be that the young human heart does not
need all the Na channels for impulse propagation, and that
50% of the channels still provide enough charge carriers for
(almost) normal conduction. It would be interesting to
know whether these patients have only 50% of INa and
whether they have a reduced upstroke velocity of their
action potential, especially under conditions of impedance
loading. A compensatory mechanism could very well explain
the phenotype. For example, it may be interesting to know
whether coupling is normal or whether the decrease in INa
is compensated with a change in coupling. Some of these
important questions could be addressed in an animal model
with targeted disruption of the SCN5A gene. Such a model
has been established, most recently in the mouse (20).
Myocytes from adult heterozygous SCN5A / mice show
a 50% reduction in their inward Na current amplitude. In
these mice, the heart rate was slowed by about 9% (10% in
our patients; Fig. 3), the PR interval increased by 35% (38%
in our patients), the P-wave duration increased by 27% (vs.
20% in our patients) and the QT duration was unchanged
(as in our patients). Although the electrophysiology char-
acteristics of the mouse heart markedly differ from those of
the human heart (21), the phenotype of the SCN5A /
mouse is in agreement with our conclusion that the hered-
itary Lene`gre disease is caused by an haploinsufficiency
mechanism. It will be of major interest to determine
whether the hearts from SCN5A / mice undergo age-
related changes in their conduction parameters.
Mutations in the SCN5A gene have been associated with
Figure 5. Evolution with aging of conduction parameters in affected (filled
symbols) and unaffected subjects (open symbols). (A) Averaged and
filtered P-wave duration. (B) PR duration. (C) QRS duration. In A and B,
data were fitted with a linear regression analysis. In C, assessment of the
residuals showed that the linear model was poorly adapted to fit the relation
between QRS duration and aging in affected members. The variance was
significantly different before and after the age of 40 (ratio variance test; p
 0.001). This was indicative of a threshold effect of age. Two linear
regression analyses were thus performed before and after the age of 40.
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different clinical entities, including long QT syndrome 3
(22), Brugada syndrome (23), and hereditary Lene`gre dis-
ease (12). Brugada syndrome, a syndrome with unique ECG
anomalies (RBBB and ST-segment elevation in the precor-
dial leads) and a risk of ventricular fibrillation, can also be
caused by a 50% reduction in SCN5A functional expression
(24). We have shown that conduction anomalies are also
typical of Brugada syndrome related to SCN5A but not of
Brugada syndrome related to other genes (25). Comparison
of conduction parameters between the 25 carriers of the
exon 22-SCN5A mutant and a group of 29 SCN5A-related
Brugada patients from our own series (13 families) showed
no obvious difference, except for the QRS complex, which
may be slightly wider in the exon 22-SCN5A population
(130  28 ms vs.114  24 ms; p  0.03). Thus, reduction
in the SCN5A-related Na current causes conduction
anomalies in the Brugada syndrome as in hereditary Le-
ne`gre disease. However, none of the 25 gene carriers from
the present pedigree presented abnormal ST-segment ele-
vation. Then, why does haploinsufficiency lead to Brugada
syndrome in some families and to hereditary Lene`gre
disease in others? We have most recently reported a large
family in which the same G1406R SCN5A missense muta-
tion causes either Brugada syndrome or hereditary Lene`gre
disease, depending on the family member (16). Similar to
the splice mutation reported here, the G1406R mutation
located between the DIII-S5 and DIII-S6 domain of the
Na channel showed no detectable Na current in expres-
sion studies in spite of normal protein trafficking. This
observation suggests that the specific phenotype depends
not only on the SCN5A mutation but also on the balance
between the other ion channels, and that so-called modifier
genes could interfere with the phenotype. Most interest-
ingly, a second Brugada syndrome locus (3p22-25) (26) has
been recently identified very close to the 3p21 locus con-
taining SCN5A. Although the identity of the gene at
3p22-25 is not yet known, it certainly interferes with the
electrophysiologic function of the heart. It is thus possible
that minor differences (polymorphisms) in that gene could
modulate the consequence of a SCN5A mutation (no re-
combination event occurred between locus 3p22-25 and
3p21 in any patient carrying the IVS.222 T3C muta-
tion). Further confirmation of that hypothesis will await
identification of the gene contained within 3p22-25.
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